HomeProductsBuilding BlocksHeterocyclic ScaffoldsAliphatic HeterocyclesRelebactam
Chemical structure of CAS 1174018-99-5

Relebactam

CAS No.1174018-99-5
MDL No.MFCD28502833
MFC12H20N4O6S
MW348.38
InChI KeySMOBCLHAZXOKDQ-ZJUUUORDSA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.1174018-99-5
Product NameRelebactam

Associated Conditions

hematopoietic and lymphoid cell neoplasm·urinary tract infection·infectious disease·pyelonephritis·infection·
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Pharmacokinetics and Pharmacodynamics of β-Lactamase Inhibitors.

Pharmacotherapy • Vol. 39, Issue 2 • 2019
PMID: 30589457DOI: 10.1002/phar.2210

Pharmacokinetics, Safety, and Tolerability of Single and Multiple Doses of Relebactam, a β-Lactamase Inhibitor, in Combination with Imipenem and Cilastatin in Healthy Participants.

Antimicrobial agents and chemotherapy • Vol. 62, Issue 9 • 2018
PMID: 29914955PMC: PMC6125551DOI: 10.1128/AAC.00280-18

Relebactam Is a Potent Inhibitor of the KPC-2 β-Lactamase and Restores Imipenem Susceptibility in KPC-Producing Enterobacteriaceae.

Antimicrobial agents and chemotherapy • Vol. 62, Issue 6 • 2018
PMID: 29610205PMC: PMC5971601DOI: 10.1128/AAC.00174-18

Inactivation of the Pseudomonas-Derived Cephalosporinase-3 (PDC-3) by Relebactam.

Antimicrobial agents and chemotherapy • Vol. 62, Issue 5 • 2018
PMID: 29530851PMC: PMC5923161DOI: 10.1128/AAC.02406-17

Documentation

Similar Products